Beta Bionics, Inc. Common Stock (BBNX) is a Healthcare · Medical Devices company listed on NASDAQ. Price $21.80 (+1.73%), Market cap $0.42B, 52-week low–high $8.86 ~ $31.99.
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license a
Financial statements, price targets, institutional (13F) holdings and related news for Beta Bionics, Inc. Common Stock are updated in real time on BlackAll Trade.
Beta Bionics, Inc. Common Stock trades at $21.80 (+1.73%). Real-time quotes and charts are available on BlackAll Trade.
Beta Bionics, Inc. Common Stock has a market cap of about $0.42B.
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring peo